Assessing Neurofilaments as Biomarkers of Neuroprotection in Progressive Multiple Sclerosis: From the MS-STAT Randomized Controlled Trial

BACKGROUND AND OBJECTIVES: Improved biomarkers of neuroprotective treatment are needed in progressive multiple sclerosis (PMS) to facilitate more efficient phase 2 trial design. The MS-STAT randomized controlled trial supported the neuroprotective potential of high-dose simvastatin in secondary prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Thomas E., Holdsworth, Katherine P., Nicholas, Jennifer M., Eshaghi, Arman, Katsanouli, Theodora, Wellington, Henrietta, Heslegrave, Amanda, Zetterberg, Henrik, Frost, Chris, Chataway, Jeremy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759719/
https://www.ncbi.nlm.nih.gov/pubmed/35031587
http://dx.doi.org/10.1212/NXI.0000000000001130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759719/
https://www.ncbi.nlm.nih.gov/pubmed/35031587
http://dx.doi.org/10.1212/NXI.0000000000001130

Ejemplares similares